Rebound Therapeutics Corporation Completes Series B Financing

Represented Rebound Therapeutics Corporation in connection with the initial closing of its Series B Preferred Stock financing. The round has been fully subscribed for a total purchase price of $16.5 million. R

Rebound Therapeutics is an Orange County medical device company with a proprietary technology platform comprised of state-of-the-art imaging and illumination technologies for use during many minimally invasive surgical (MIS) procedures. When used together, Rebound’s single-use, disposable MIS access and therapeutic devices are expected to disrupt the way many MIS procedures are currently performed, including the displacement of the large, complex, capital equipment being used in operating rooms today. The Rebound platform technologies can be adapted for a variety of surgical procedures including neurosurgery, spine and orthopedic surgery, thoracic and general abdominal surgery.